Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'COMPARING CISPLATIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 45 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tester, W; Mora, J
      Innovative treatments for advanced non-small cell lung cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    2. Favalli, G; Odicino, F; Torri, V; Pecorelli, S
      Early stage ovarian cancer: the Italian contribution to clinical research.An update

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    3. Robinet, G; Thomas, P; Breton, JL; Lena, H; Gouva, S; Dabouis, G; Bennouna, J; Souquet, PJ; Balmes, P; Thiberville, L; Fournel, P; Quoix, E; Riou, R; Rebattu, P; Perol, M; Paillotin, D; Mornex, F
      Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Francais de Pneumo-Cancerologie (GFPC) Protocol 95-1

      ANNALS OF ONCOLOGY
    4. Im, DD; McGuire, WP; Rosenshein, NB
      Contemporary management of ovarian cancer

      OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
    5. Schuler, M; Herrmann, R; De Greve, JLP; Stewart, AK; Gatzemeier, U; Stewart, DJ; Laufman, L; Gralla, R; Kuball, J; Buhl, R; Heussel, CP; Kommoss, F; Perruchoud, AP; Shepherd, FA; Fritz, MA; Horowitz, JA; Huber, C; Rochlitz, C
      Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: Results of a multicenter phase II study

      JOURNAL OF CLINICAL ONCOLOGY
    6. Socinski, MA; Sandler, AB; Miller, LL; Locker, PK; Hanover, CK; Elfring, GL; Israel, VK; Pirotta, N; Natale, RB
      Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    7. Kelly, K; Crowley, J; Bunn, PA; Presant, CA; Grevstad, PK; Mainpour, CM; Ramsey, SD; Wozniak, AJ; Weiss, GR; Moore, DF; Israel, VK; Livingston, RB; Gandara, DR
      Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-celllung cancer: A Southwest Oncology Group trial

      JOURNAL OF CLINICAL ONCOLOGY
    8. Khuri, FR; Rigas, JR; Figlin, RA; Gralla, RJ; Shin, DM; Munden, R; Fox, N; Huyghe, MR; Kean, Y; Reich, SD; Hong, WK
      Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    9. Inoue, A; Saijo, N
      Recent advances in the chemotherapy of non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    10. Sorenson, S; Glimelius, B; Nygren, P
      A systematic overview of chemotherapy effects in non-small cell lung cancer

      ACTA ONCOLOGICA
    11. Horvath, L; Boyer, M; Clarke, S; Beale, P; Beith, J; Underhill, C; Stockler, M; Bishop, J
      Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer

      LUNG CANCER
    12. Comella, P
      Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer

      SEMINARS IN ONCOLOGY
    13. Pujol, JL; von Pawel, J; Tumolo, S; Martoni, A; Hearn, S; Fields, SZ; Ross, G
      Preliminary results of combined therapy with topotecan and carboplatin in advanced non-small-cell lung cancer

      ONCOLOGY
    14. Gibbs, DD; Gore, ME
      Pursuit of optimum outcomes in ovarian cancer - Methodological approaches to therapy

      DRUGS
    15. Cardenes, H; Randall, ME
      Integrating radiation therapy in the curative management of ovarian cancer: Current issues and future directions

      SEMINARS IN RADIATION ONCOLOGY
    16. White, SC; Anderson, H; Jayson, GC; Ashcroft, L; Ranson, M; Thatcher, N
      Randomised phase II study of cisplatin-etoposide versusinfusional carboplatin in advanced non-small-cell lung cancer and mesothelioma

      ANNALS OF ONCOLOGY
    17. Vermorken, JB
      Optimal treatment for ovarian cancer: taxoids and beyond

      ANNALS OF ONCOLOGY
    18. von Pawel, J; von Roemeling, R; Gatzemeier, U; Boyer, M; Elisson, LO; Clark, P; Talbot, D; Rey, A; Butler, TW; Hirsh, V; Olver, I; Bergman, B; Ayoub, J; Richrdson, G; Dunlop, D; Arcenas, A; Vescio, R; Viallet, J; Treat, J
      Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group

      JOURNAL OF CLINICAL ONCOLOGY
    19. Kucuk, O; Shevrin, DH; Pandya, KJ; Bonomi, PD
      Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer - An Eastern Cooperative Oncology Group study (PB586)

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    20. Chen, YM; Perng, RP; Yang, KY; Lin, WC; Wu, HW; Liu, JM; Tsai, CM; Whang-Peng, J
      A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    21. Chen, YM; Perng, RP; Whang-Peng, J; Wu, HW; Lin, WC; Tsai, CM
      Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer

      LUNG CANCER
    22. Chen, YM; Perng, RP; Yang, KY; Lin, WC; Wu, HW; Tsai, CM; Whang-Peng, J
      Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy

      LUNG CANCER
    23. Sweeney, CJ; Sandler, AB
      Chemotherapy in non-small cell lung cancer

      INVESTIGATIONAL NEW DRUGS
    24. Young, RC
      Three cycles versus six cycles of adjuvant paclitaxel (Taxol)/carboplatin in early stage ovarian cancer

      SEMINARS IN ONCOLOGY
    25. Mahe, MA; Fumoleau, P; Fabbro, M; Guastalla, JP; Faurous, P; Chauvot, P; Chetanoud, L; Classe, JM; Rouanet, P; Chatal, JF
      A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma

      CLINICAL CANCER RESEARCH
    26. Jassem, J
      Chemotherapy of advanced non-small cell lung cancer

      ANNALS OF ONCOLOGY
    27. Partridge, EE; Barnes, MN
      Epithelial ovarian cancer: Prevention, diagnosis, and treatment

      CA-A CANCER JOURNAL FOR CLINICIANS
    28. Muginova, SV; Vil'ms, EV; Shekhovtsova, TN; Ivanov, VB
      Inhibition of peroxidase, trypsin, and alpha-chymotrypsin by platinum (II)and platinum (IV) complexes

      BIOCHEMISTRY-MOSCOW
    29. LOKICH J; ANDERSON N
      CARBOPLATIN VERSUS CISPLATIN IN SOLID TUMORS - AN ANALYSIS OF THE LITERATURE

      Annals of oncology
    30. FYLES AW; THOMAS GM; PINTILIE M; ACKERMAN I; LEVIN W
      A RANDOMIZED STUDY OF 2 DOSES OF ABDOMINOPELVIC RADIATION-THERAPY FORPATIENTS WITH OPTIMALLY DEBULKED STAGE-I, STAGE-II, AND STAGE-III OVARIAN-CANCER

      International journal of radiation oncology, biology, physics
    31. YOUNG RC; PECORELLI S
      MANAGEMENT OF EARLY OVARIAN-CANCER

      Seminars in oncology
    32. LANCIANO R; REDDY S; CORN B; RANDALL M
      UPDATE ON THE ROLE OF RADIOTHERAPY IN OVARIAN-CANCER

      Seminars in oncology
    33. GADDUCCI A; SARTORI E; MAGGINO T; ZOLA P; LANDONI F; FANUCCHI A; STEGHER C; ALESSI C; BUTTITTA F; BERGAMINO T
      ANALYSIS OF FAILURES IN PATIENTS WITH STAGE-I OVARIAN-CANCER - AN ITALIAN MULTICENTER STUDY

      International journal of gynecological cancer
    34. SORBE B; NORDQVIST S
      ADJUVANT RADIOTHERAPY IN EARLY-STAGE OVARIAN-CARCINOMA

      International journal of oncology
    35. FYLES A
      IS ABDOMINOPELVIC RADIATION-THERAPY THE OPTIMAL TREATMENT FOR COMPLETELY RESECTED STAGE-I AND STAGE-II HIGH-RISK OVARIAN-CANCER - PRO

      European journal of cancer
    36. BOLIS G; FERRARIS C; PARAZZINI F
      IS ABDOMINOPELVIC RADIATION-THERAPY THE OPTIMAL TREATMENT FOR COMPLETELY RESECTED STAGE-I AND STAGE-II HIGH-RISK OVARIAN-CANCER - CONTRA

      European journal of cancer
    37. GADDUCCI A; BRUNETTI I; COSIO S; GIANNESSI PG; GENAZZANI AR; CONTE P
      PLATINUM COMPOUNDS AND PACLITAXEL IN ADVANCED EPITHELIAL OVARIAN-CANCER

      Anticancer research
    38. COLEMAN RL; MILLER DS
      TOPOTECAN IN THE TREATMENT OF GYNECOLOGIC CANCER

      Seminars in oncology
    39. TROPE C; KRISTENSEN G
      CURRENT STATUS OF CHEMOTHERAPY IN GYNECOLOGIC CANCER

      Seminars in oncology
    40. COLLEONI M; BONI L; VICARIO G; PANCHERI F; SGARBOSSA G; NELLI P; CALABRO F; TONIOLO L; BORTOLOTTI L; MANENTE P
      A DOSE-ESCALATING STUDY OF CARBOPLATIN COMBINED WITH VINORELBINE IN NON-SMALL-CELL LUNG-CANCER

      Oncology
    41. HURWITZ HI; MCGUIRE WP
      PRIMARY CHEMOTHERAPY IN EPITHELIAL OVARIAN-CANCER

      Obstetrics and gynecology clinics of North America
    42. RUCKDESCHEL JC
      THE FUTURE-ROLE OF CARBOPLATIN

      Seminars in oncology
    43. COLOMBO N; MAGGIONI A; VIGNALI M; PARMA G; MANGIONI C
      OPTIONS FOR PRIMARY CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - THE EUROPEAN PERSPECTIVE

      Gynecologic oncology
    44. PROVE AM; DIRIX LY; SCHRIJVERS D; VANOOSTEROM AT
      THE MANAGEMENT OF OVARIAN-CANCER

      Annals of oncology
    45. LEVIN L; SIMON R; HRYNIUK W
      IMPORTANCE OF MULTIAGENT CHEMOTHERAPY REGIMENS IN OVARIAN-CARCINOMA -DOSE INTENSITY ANALYSIS

      Journal of the National Cancer Institute


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 20:45:54